New drug aims to reignite motivation in Parkinson's patients

NCT ID NCT07461220

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called IRL757 in 75 people with Parkinson's disease who also have apathy (loss of interest or motivation). The main goal is to see if the drug is safe and tolerable over 12 weeks. Researchers will also check if it helps improve apathy symptoms compared to a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Centrum Medyczne NEUROMED

    RECRUITING

    Bydgoszcz, Poland

  • Centrum Medyczne NeuroProtect

    NOT_YET_RECRUITING

    Warsaw, Poland

  • EuroMedis Sp. z o.o.

    RECRUITING

    Szczecin, Poland

  • First University Multiprofile Hospital for Active Treatment MHAT - Neurology Clinic

    RECRUITING

    Sofia, Bulgaria

  • Hospital General Universitario de Elche

    NOT_YET_RECRUITING

    Elche, Spain

  • Hospital Universitario Ramon y Cajal

    RECRUITING

    Madrid, Spain

  • Hospital de la Santa Creu i Sant Pau, Unidad de trastornos del movimiento

    RECRUITING

    Barcelona, Spain

  • Medical Center "Galileo" OOD

    RECRUITING

    Pleven, Bulgaria

  • Neuro-Care sp. z o.o. sp. Komandytowa

    RECRUITING

    Katowice, Poland

  • NeuroKlinika Prof. Andrzej Bogucki

    RECRUITING

    Lodz, Poland

  • Neurologie Berlin

    RECRUITING

    Berlin, Germany

  • Universitaetsklinikum Carl Gustav Carus

    NOT_YET_RECRUITING

    Dresden, Germany

  • University Multiprofile Hospital for Active Treatment "Alexandrovska" EAD, Clinic of Neurological Diseases

    NOT_YET_RECRUITING

    Sofia, Bulgaria

More trials for these conditions

Other studies related to the condition(s) this trial covers.